NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - JOHNSON & JOHNSON - 2.02 / 8.01 / 9.01
Filed:
2026-04-14
AccNo:
0000200406-26-000076
Size:
965 KB
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
发布时间04/14 11:35 UTC
首次发现04/14 11:40 UTC
热度106.4
重要度76
情绪+0.04
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 747 字符
Form 8-K - Current report: SEC Accession No. 0000200406-26-000076
Filing Date: 2026-04-14
Accepted: 2026-04-14 07:35:25
Documents: 19
Period of Report: 2026-04-14
Items: Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
JOHNSON & JOHNSON (Filer) CIK : 0000200406 (see all company filings) EIN. : 221024240 | State of Incorp.: NJ | Fiscal Year End: 1228 Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 26859172 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | jnj-20260414.htm iXBRL | 8-K
2 | EX-99.1 | a2026q1exhibit991.htm | EX-99.1
3 | EX-99.2 | a2026q1exhibit992.htm | EX-99.2
4 | EX-99.3 | a2026q1exhibit993.htm | EX-99.3